Medigen partners with WHO initiative to offer its COVID-19 vaccine technology
Taipei, Aug. 29 (CNA) Medigen Vaccine Biologics Corp., the manufacturer of the only domestically-made COVID-19 vaccine that has received emergency use authorization in Taiwan, on Tuesday announced its out-licensing agreement with a World Health Organization (WHO) initiative, which would make the vaccine technology available to others.